Cargando…
A novel prognostic signature for lung adenocarcinoma based on cuproptosis-related lncRNAs: A Review
Lung adenocarcinoma (LUAD) is a highly heterogeneous disease with complex pathogenesis, high mortality, and poor prognosis. Cuproptosis is a new type of programmed cell death triggered by copper accumulation that may play an important role in cancer. LncRNAs are becoming valuable prognostic factors...
Autores principales: | Di, Huang, Zhao, Jiting, Zhu, Xue, Zhou, Xinpeng, Hu, Yuanlong, Wang, Mengjie, Qiu, Zhanjun, Zhang, Wei, Chen, Xianhai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750635/ https://www.ncbi.nlm.nih.gov/pubmed/36626411 http://dx.doi.org/10.1097/MD.0000000000031924 |
Ejemplares similares
-
A prognostic and immunotherapy effectiveness model for pancreatic adenocarcinoma based on cuproptosis-related lncRNAs signature
por: Zhang, Ning, et al.
Publicado: (2023) -
Establishment of a prognostic signature for lung adenocarcinoma using cuproptosis-related lncRNAs
por: Yalimaimaiti, Saiyidan, et al.
Publicado: (2023) -
Construction of a pyroptosis-related lncRNAs signature for predicting prognosis and immunotherapy response in glioma
por: Huang, Qianrong, et al.
Publicado: (2023) -
A novel cuproptosis-related prognostic 2-lncRNAs signature in breast cancer
por: Xu, Qi-Tong, et al.
Publicado: (2023) -
Cuproptosis-related prognostic signatures predict the prognosis and immunotherapy in HCC patients
por: Peng, Hong, et al.
Publicado: (2023)